Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Imiquimod & Keratosis actinica, Imiquimod cream (various strengths, e.g., 5% and 3.75%) is approved by the US Food and Drug Administration for the topical treatment of Keratosis actinica on sun‑exposed areas such as the face and scalp (1, 2). It is an immune‑response modifier (TLR7 agonist) and one of the established field‑directed therapies for actinic keratoses in US practice guidelines and reviews (1, 3).
(1)
(2)
(3) Zhang …